Sort
82,697 grants matching “vaccine development”
Sequencing Technology Core
$1,001,799Donna Muzny · Baylor College Of Medicine · U19 · FY2019 · AI
Clinical Support
$1,001,704James J Vredenburgh · Duke University · P01 · FY2016 · CA
Interaction of HIV envelope with cell surface receptors
$1,001,661Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Epstein-Barr Virus Associated Disorders
$1,001,637Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Development Of Vaccines For Genital Herpes Simplex Infection
$1,001,637Jeffrey Cohen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Clinical Core
$1,001,600Cornelia L Dekker · Stanford University · U19 · FY2012 · AI
Understanding antibody responses and defining correlates of protection for endemic and pandemic coronavirus strains
$1,001,583Viviana A Simon · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit
$1,001,368Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2025 · AI
ANTIGEN-SPECIFIC VACCINES FOR BREAST CANCER
$1,001,273Johns Hopkins University · U19 · FY2001 · CA
Non-Viral Pandemic Influenza Vaccine Development
$1,001,081Gary Fujii · Molecular Express, Inc. · U01 · FY2008 · AI
Structural Biology of Influenza Epitopes
$1,000,656Audray Harris · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
JHU-MCAIDS HPTN TRIAL SITE-CHINA
$1,000,586Johns Hopkins University · U01 · FY2001 · AI
Establishment/Maintenance of Biomedical Research Colony
$1,000,578Thomas J. Rowell · University Of Louisiana At Lafayette · U42 · FY2008 · RR
IMPAACT INVESTIGATIONS FOR FUTURE STUDIES
$1,000,503Barbara Driver · Westat, Inc. · N01 · FY2020 · HD
Boston Pediatric AIDS Clinical Trials Unit
$1,000,257Children'S Hospital Boston · U01 · FY2005 · AI
Structural Biology of Influenza Epitopes
$1,000,090Audray Harris · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Preclinical development of a biological antiviral for universal influenza treatment and prophylaxis using a novel nucleic acid delivery platform
$1,000,088Lyndsey Linke · Sivec Biotechnologies, Llc · R44 · FY2022 · AI
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer
$1,000,028Anne Rietz · Kovina Therapeutics Inc. · R44 · FY2024 · CA
JHU-MCAIDS HPTN TRIAL SITE-CHINA
$1,000,001Johns Hopkins University · U01 · FY2000 · AI
Rapid Portable HIV Detection and Monitoring System for Low Resource Settings
$1,000,001Joel W. Grover · Thermal Gradient, Inc. · R44 · FY2010 · AI
Treatment of Peanut Allergy with Intradermal Administration of ASP0892 (ARA-LAMP-vax): A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Study
$1,000,001Robert A Wood · Johns Hopkins University · UM2 · FY2021 · AI
Protective vaccine for H5N1 Flu using H5 protein and a novel TLR4 agonist.
$1,000,000Christopher H Clegg · Tria Bioscience Corporation · R44 · FY2012 · AI
Therapy and Prophylaxis for Genital Tract Infection
$1,000,000Dominick Auci · Therapyx, Inc. · SB1 · FY2024 · AI
Respiratory Virus Vaccine and Adjuvant Exploration
$1,000,000Ralph S Baric · Univ Of North Carolina Chapel Hill · U01 · FY2019 · AI
Environmental Causes of Type 1 Diabetes
$1,000,000University Of Colorado Denver · U01 · FY2003 · DK